Literature DB >> 30605058

Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.

Ka Yi G Koo1, Tom A Schweizer1,2,3,4,5, Corinne E Fischer1,2,6, David G Munoz1,7,8.   

Abstract

BACKGROUND: The Apolipoprotein (APOE) ε4 allele is a well-known risk factor for Alzheimer's Disease (AD), and sleep disturbances are commonly associated with AD. However, few studies have investigated the relationship between APOE ε4 and abnormal sleep patterns (N+) in AD.
OBJECTIVE: To examine the relationship between APOE genotype, Lewy body pathology, and abnormal sleep patterns in a large group of subjects with known AD load evaluated upon autopsy.
METHOD: Data from 2,368 cases obtained from the National Alzheimer's Coordinating Centre database were categorized as follows: Braak Stage V/VI and CERAD frequent neuritic plaques as high load AD, Braak Stage III/IV and moderate CERAD as intermediate load AD, and Braak Stage 0/I/II and infrequent CERAD as no to low load AD. Cases discrepant between the two measures were discarded.
RESULTS: Disrupted sleep was more frequent in males (42.4%) compared to females (35.1%), and in carriers (42.3%) as opposed to non-carriers (36.5%) of ε4. Amongst female subjects with high AD load and Lewy body pathology, homozygous (ε4/ε4) carriers experienced disrupted sleep more often compared with heterozygous (ε4/x) or non-carriers of ε4. Such recessive, gender-specific, and Lewy body association is reminiscent of the ε4 effect on psychosis in AD. However, such association was lost after adjusting for covariates. In subjects with no to low AD pathology, female ε4 carriers had significantly more nighttime disturbances than non-carriers; this effect is independent of the presence of Lewy body pathology.
CONCLUSION: The influence of APOE ε4 on sleep disturbances is dependent on gender and severity of AD load. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's Disease; Lewy bodies; apolipoprotein E; gender; neuropathology; risk factors; sleep behaviours.

Mesh:

Substances:

Year:  2019        PMID: 30605058      PMCID: PMC6613208          DOI: 10.2174/1567205016666190103161034

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  26 in total

1.  Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.

Authors:  Dong-Wan Chen; Jun Wang; Li-Li Zhang; Yan-Jiang Wang; Chang-Yue Gao
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease.

Authors:  Y Stern; D Jacobs; J Goldman; E Gomez-Tortosa; B T Hyman; Y Liu; J Troncoso; K Marder; M X Tang; J Brandt; M Albert
Journal:  Arch Neurol       Date:  2001-03

Review 3.  Alzheimer's disease: clinical implications of the apolipoprotein E genotype.

Authors:  M R Farlow
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

Review 4.  Current treatments for sleep disturbances in individuals with dementia.

Authors:  Cynthia L Deschenes; Susan M McCurry
Journal:  Curr Psychiatry Rep       Date:  2009-02       Impact factor: 5.285

5.  Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.

Authors:  Jerome A Yesavage; Leah Friedman; Helena Kraemer; Jared R Tinklenberg; Ahmad Salehi; Art Noda; Joy L Taylor; Ruth O'Hara; Greer Murphy
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-03       Impact factor: 2.680

6.  Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Authors:  Andrew S P Lim; Lei Yu; Matthew Kowgier; Julie A Schneider; Aron S Buchman; David A Bennett
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

7.  Sex modifies the APOE-related risk of developing Alzheimer disease.

Authors:  Andre Altmann; Lu Tian; Victor W Henderson; Michael D Greicius
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

8.  Evidence of association between sleep quality and APOE ε4 in healthy older adults: A pilot study.

Authors:  Lauren L Drogos; Stephanie J Gill; Amanda V Tyndall; Jill K Raneri; Jillian S Parboosingh; Aileen Naef; Kyle D Guild; Gail Eskes; Patrick J Hanly; Marc J Poulin
Journal:  Neurology       Date:  2016-10-25       Impact factor: 9.910

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.

Authors:  Kate E Sprecher; Rebecca L Koscik; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Ozioma C Okonkwo; Mark A Sager; Sanjay Asthana; Sterling C Johnson; Ruth M Benca; Barbara B Bendlin
Journal:  Neurology       Date:  2017-07-05       Impact factor: 9.910

View more
  3 in total

Review 1.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 2.  Possible Neuropathology of Sleep Disturbance Linking to Alzheimer's Disease: Astrocytic and Microglial Roles.

Authors:  Shu-Yun Xiao; Yi-Jie Liu; Wang Lu; Zhong-Wei Sha; Che Xu; Zhi-Hua Yu; Shin-Da Lee
Journal:  Front Cell Neurosci       Date:  2022-06-09       Impact factor: 6.147

Review 3.  Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway.

Authors:  Victoria M Pak; S-Hakki Onen; Donald L Bliwise; Nancy G Kutner; Katherine L Russell; Fannie Onen
Journal:  Front Aging Neurosci       Date:  2020-05-08       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.